ESOPHAGEAL SQUAMOUS CELL CARCINOMAS
Clinical trials for ESOPHAGEAL SQUAMOUS CELL CARCINOMAS explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL SQUAMOUS CELL CARCINOMAS trials appear
Sign up with your email to follow new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough esophageal cancer: drug duo targets tumors
Disease control OngoingThis study tests a new drug combination (SI-B001 plus irinotecan) in 22 adults with advanced esophageal cancer that has returned or spread and no longer responds to standard treatments. The goal is to see if the combo can shrink tumors or slow the disease. Participants receive th…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMAS
Phase: PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 05:33 UTC
-
Triple therapy shows promise against tough esophageal cancer
Disease control OngoingThis study tests a new treatment plan for people with advanced esophageal cancer that cannot be removed by surgery. Participants first receive immunotherapy plus chemotherapy, followed by chemoradiation. The goal is to see if this approach improves survival and controls the disea…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMAS
Phase: PHASE2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated May 14, 2026 12:06 UTC